Actein
CAS: 18642-44-9
Ref. TM-T7190
1mg | 142,00 € | ||
5mg | 305,00 € | ||
10mg | 460,00 € | ||
25mg | 736,00 € | ||
50mg | 994,00 € | ||
1mL*10mM (DMSO) | 415,00 € |
Información del producto
- (2S,4aR,5aR,7R,7aR,7bR,8R,12aS,12bS,14aR)-4'-hydroxy-1,1,5',7a,8,12a-hexamethyl-2-(beta-D-xylopyranosyloxy)hexadecahydro-2H-spiro[cyclopropa[1',8a']naphtho[2',1':4,5]indeno[2,1-b]pyran-10,2'-[3,6]dioxabicyclo[3.1.0]hexan]-7-yl acetate
- (3beta,12beta,16beta,23R,24R,25S,26S))-12-(Acetyloxy)-16,23:23,26:24,25-triepoxy-26-hydroxy-9,19-cycloanostan-3-yl beta-D-xylopyranoside
- (3β,12β,16β,23R,24R,25S,26S)-12-(Acetyloxy)-16,23:23,26:24,25-triepoxy-26-hydroxy-9,19-cyclolanostan-3-yl β-<span class="text-smallcaps">D</span>-xylopyranoside
- 9,19-Cyclolanostane, β-<span class="text-smallcaps">D</span>-xylopyranoside deriv.
- Shengmating
- Spiro[5H-cyclopropa[1′,8′a]naphth[2′,1′:4,5]indeno[2,1-b]pyran-10(2H),2′-[3,6]dioxabicyclo[3.1.0]hexane], β-<span class="text-smallcaps">D</span>-xylopyranoside deriv.
- β-<span class="text-smallcaps">D</span>-Xylopyranoside, (3β,12β,16β,23R,24R,25S,26S)-12-(acetyloxy)-16,23:23,26:24,25-triepoxy-26-hydroxy-9,19-cyclolanostan-3-yl
Actein stimulates bone formation, counters osteoporosis and oxidative damage, and may treat lipid disorders and cancer, inhibiting breast cancer cell growth.
Propiedades químicas
Consulta técnica sobre: TM-T7190 Actein
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.